Search results

Page results

• Anti bribery statement - our commitment

  At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.

• Getting ready for surgery: Bowel preparation with a laxative and antibiotics

  This information is for patients having gynaecology surgery who may also need bowel (colorectal) surgery as part of their cancer treatment.

• New precision medicine study for patients with cancer in the biliary tract

  A new study at UCLH and UCL aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile of their tumour.

• UCLH doses first patient in the world in Covid-19 antibody trial

  UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Breathing aids developed by UCL, UCLH and F1 team delivered to 40 NHS hospitals

  Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.

• Surviving coronavirus - patients speak about the impact of the disease

  Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.